The NORLUX Neuro-Oncology laboratory was set up through a collaborative agreement between LIH and the University of Bergen in Norway based on an extensive collaboration with Prof. Rolf Bjerkvig from the Department of Biomedicine at the University of Bergen. The mission of our lab is to improve the life and prognosis of people affected by a malignant brain tumor.  

We aim to improve the treatment options for malignant brain tumors, with a focus on diffuse gliomas. With a radically translational approach to research, we work with patient samples and innovative patient-derived preclinical model systems that recapitulate the patient tumor. Our research investigates the cellular and molecular basis of gliomas, their capacity to invade the normal brain and escape therapy. Special areas of interests are tumor plasticity, tumor heterogeneity, tumor metabolism, immuno-oncology and pharmacogenomics.